Literature DB >> 29135777

Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.

Margaret C Fang1, Dongjie Fan, Sue Hee Sung, Daniel M Witt, John R Schmelzer, Steven R Steinhubl, Steven H Yale, Alan S Go.   

Abstract

BACKGROUND: Administrative data are frequently used to identify venous thromboembolism (VTE) for research and quality reporting. However, the validity of these codes, particularly in outpatients, has not been well-established.
OBJECTIVE: To determine how well International Classification of Diseases, Ninth Revision (ICD-9) codes for VTE predict chart-confirmed acute VTE in inpatient and outpatients. PATIENTS AND METHODS: We selected 4642 adults with an incident ICD-9 diagnosis of VTE between years 2004 and 2010 from the Cardiovascular Research Network Venous Thromboembolism cohort study. Medical charts were reviewed to determine validity of events. Positive predictive values (PPVs) of ICD-9 codes were calculated as the number of chart-validated VTE events divided by the number with specific VTE codes. Analyses were stratified by VTE type [pulmonary embolism (PE), deep venous thrombosis (DVT)], code position (primary, secondary), and setting [hospital/emergency department (ED), outpatient].
RESULTS: The PPV for any diagnosis of VTE was 64.6% for hospital/ED patients and 30.9% for outpatients. Primary diagnosis codes from hospital/ED patients were more likely to represent acute VTE than secondary diagnosis codes (78.9% vs. 44.4%, P<0.001). Primary hospital/ED codes for PE and lower extremity DVT had higher PPV than for upper extremity DVT (89.1%, 74.9%, and 58.1%, respectively). Outpatient codes were poorly predictive of acute VTE: 28.0% for PE and 53.6% for lower extremity DVT.
CONCLUSIONS: ICD-9 codes for VTE obtained from outpatient encounters or from secondary diagnosis codes do not reliably reflect acute VTE. More accurate ways of identifying VTE in outpatients are needed before these codes can be adopted for research or policy purposes.

Entities:  

Mesh:

Year:  2017        PMID: 29135777      PMCID: PMC5125903          DOI: 10.1097/MLR.0000000000000524

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  14 in total

1.  ICD-9 Code-Based Venous Thromboembolism Performance Targets Fail to Measure Up.

Authors:  Brandyn D Lau; Elliott R Haut; Deborah B Hobson; Peggy S Kraus; Chepkorir Maritim; J Matthew Austin; Kenneth M Shermock; Bhunesh Maheshwari; Paul X Allen; Aileen Almario; Michael B Streiff
Journal:  Am J Med Qual       Date:  2015-04-21       Impact factor: 1.852

2.  The validity of ICD-9-CM codes in identifying postoperative deep vein thrombosis and pulmonary embolism.

Authors:  Chunliu Zhan; James Battles; Yen-Pin Chiang; David Hunt
Journal:  Jt Comm J Qual Patient Saf       Date:  2007-06

Review 3.  A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.

Authors:  Leonardo Tamariz; Thomas Harkins; Vinit Nair
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

4.  Prevalence of clinical venous thromboembolism in the USA: current trends and future projections.

Authors:  S B Deitelzweig; B H Johnson; J Lin; K L Schulman
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

5.  Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop.

Authors:  Gary E Raskob; Roy Silverstein; Dale W Bratzler; John A Heit; Richard H White
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

6.  Do postoperative complications vary by hospital teaching status?

Authors:  Smruti Vartak; Marcia M Ward; Thomas E Vaughn
Journal:  Med Care       Date:  2008-01       Impact factor: 2.983

7.  Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure.

Authors:  Karl Y Bilimoria; Jeanette Chung; Mila H Ju; Elliott R Haut; David J Bentrem; Clifford Y Ko; David W Baker
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

8.  Hospitalizations of adults ≥60 years of age with venous thromboembolism.

Authors:  Hussain R Yusuf; Nimia Reyes; Qing C Zhang; Ekwutosi M Okoroh; Azfar-E-Alam Siddiqi; James Tsai
Journal:  Clin Appl Thromb Hemost       Date:  2013-06-27       Impact factor: 2.389

9.  Predictive value of the present-on-admission indicator for hospital-acquired venous thromboembolism.

Authors:  Raman R Khanna; Sharon B Kim; Ian Jenkins; Robert El-Kareh; Nasim Afsarmanesh; Alpesh Amin; Heather Sand; Andrew Auerbach; Catherine Y Chia; Gregory Maynard; Patrick S Romano; Richard H White
Journal:  Med Care       Date:  2015-04       Impact factor: 2.983

10.  Determinants of venous thromboembolism among hospitalizations of US adults: a multilevel analysis.

Authors:  James Tsai; Althea M Grant; Michele G Beckman; Scott D Grosse; Hussain R Yusuf; Lisa C Richardson
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

View more
  36 in total

1.  Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.

Authors:  Christine Baumgartner; Judith Maselli; Andrew D Auerbach; Margaret C Fang
Journal:  J Gen Intern Med       Date:  2019-06-24       Impact factor: 5.128

2.  Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism.

Authors:  Craig I Coleman; Alexander G G Turpie; Thomas J Bunz; Jan Beyer-Westendorf
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

3.  Design and Implementation of a Comprehensive Surveillance System for Venous Thromboembolism in a Defined Region Using Electronic and Manual Approaches.

Authors:  Thomas L Ortel; Katie Arnold; Michele Beckman; Audrey Brown; Nimia Reyes; Ibrahim Saber; Ryan Schulteis; Bhavana Pendurthi Singh; Andrea Sitlinger; Elizabeth H Thames
Journal:  Appl Clin Inform       Date:  2019-07-31       Impact factor: 2.342

4.  The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.

Authors:  Janet N Chu; Judith Maselli; Andrew D Auerbach; Margaret C Fang
Journal:  Thromb Res       Date:  2017-04-12       Impact factor: 3.944

5.  Out-of-system Care and Recording of Patient Characteristics Critical for Comparative Effectiveness Research.

Authors:  Kueiyu Joshua Lin; Robert J Glynn; Daniel E Singer; Shawn N Murphy; Joyce Lii; Sebastian Schneeweiss
Journal:  Epidemiology       Date:  2018-05       Impact factor: 4.822

6.  Identifying Patients With High Data Completeness to Improve Validity of Comparative Effectiveness Research in Electronic Health Records Data.

Authors:  Kueiyu Joshua Lin; Daniel E Singer; Robert J Glynn; Shawn N Murphy; Joyce Lii; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2017-10-10       Impact factor: 6.875

7.  Venous Thromboembolism Prophylaxis in Neurocritical Care Patients: Are Current Practices, Best Practices?

Authors:  K M Sauro; A Soo; A Kramer; P Couillard; J Kromm; D Zygun; D J Niven; S M Bagshaw; H T Stelfox
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

8.  A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.

Authors:  Henry T Stelfox; Rebecca Brundin-Mather; Andrea Soo; Jeanna Parsons Leigh; Daniel J Niven; Kirsten M Fiest; Christopher James Doig; Danny J Zuege; Barry Kushner; Fiona Clement; Sharon E Straus; Deborah J Cook; Sean M Bagshaw; Khara M Sauro
Journal:  Intensive Care Med       Date:  2019-02-01       Impact factor: 17.440

9.  Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.

Authors:  Christine Baumgartner; Alan S Go; Dongjie Fan; Sue Hee Sung; Daniel M Witt; John R Schmelzer; Marc S Williams; Steven H Yale; Jeffrey J VanWormer; Margaret C Fang
Journal:  Thromb Res       Date:  2020-03-05       Impact factor: 3.944

10.  Accuracy of Diagnostic Coding for Sarcoidosis in Electronic Databases: A Population-Based Study.

Authors:  Patompong Ungprasert; Eric L Matteson; Cynthia S Crowson
Journal:  Lung       Date:  2017-10-09       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.